News
07-12-2010, 02:59 AM
Midatech Group Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, and Immunotope Inc, a biotechnology company focused on the development of immunotherapy products, today announced the formation of a joint venture Syntara LLC, to develop antigen based products for immune therapies to treat chronic viral infections and certain cancers.
More... (http://www.news-medical.net/news/20100712/Midatech-Immunotope-form-joint-venture-to-develop-antigen-based-products-for-immune-therapies.aspx)
More... (http://www.news-medical.net/news/20100712/Midatech-Immunotope-form-joint-venture-to-develop-antigen-based-products-for-immune-therapies.aspx)